On the recordSeptember 12, 2017
The current system also poses challenges for consumer access to potentially better, safer, innovative products.
Source
congress.govThe current system also poses challenges for consumer access to potentially better, safer, innovative products.
Gene Green discusses the limitations of the existing regulatory framework for OTC products.
Share
More from Gene Green
These numbers are troubling as we are because even more acute when you look at the existing racial, socioeconomic, and geographic disparities.
I'm happy to once again support my colleague Mr. Engel's bill, to rein in this dangerous practice.
The Cures Act aimed to build on the progress of the HITECH Act of 2009, but by focusing on improving interoperability, patient access to their health records, and reducing provider burden.